Results for this period
Third quarter1 January 2026 to 30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Net sales increased as our core contact lens business remained solid, while rising raw material costs and upfront investments reduced operating income. In the consulting business, the launch of the pharmaceutical and medical affairs consulting business contributed to higher sales. In the systems business, capturing demand contributed to higher sales, while development-related costs for the next-generation POS system and the burden of upfront investments reduced earnings.
None applicable
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026 to 30 September 2026 |
| Net Sales | ¥5,739,532 thousand (YoY +5.9%) |
| Operating profit | ¥377,366 thousand (YoY -4.5%) |
| Ordinary income | ¥382,185 thousand (YoY +0.6%) |
| Profit attributable to owners of the parent | ¥231,900 thousand (YoY -6.2%) |
| Equity ratio | End of the current fiscal period 54.3 / End of previous period 52.4 |
| Total assets | ¥5,334,822 thousand |
| Net assets | ¥2,896,092 thousand |
| Cash and cash equivalents at end of period | ¥1,804,893 thousand |
| Segment revenue | Contact Lens Business ¥5,338,607 thousand (YoY +5.7%), Consulting Business ¥43,777 thousand (YoY +75.1%), Systems Business ¥357,147 thousand (YoY +4.5%) |
| Segment profit | Contact Lens Business ¥498,591 thousand (YoY -2.7%), Consulting Business ¥23,043 thousand (YoY +86.0%), Systems Business ¥54,042 thousand (YoY -26.2%) |
| Depreciation and amortization | ¥26,062 thousand |
| Impairment loss | No applicable items |
| Breakdown of extraordinary income (loss) | Extraordinary income No applicable items / Extraordinary loss Extraordinary Losses ¥32,482 thousand |
| Disclosure regarding the going concern assumption | None applicable |
| Factors Behind Changes in Business Performance | Net sales increased as our core contact lens business remained solid, while rising raw material costs and upfront investments reduced operating income. In the consulting business, the launch of the pharmaceutical and medical affairs consulting business contributed to higher sales. In the systems business, capturing demand contributed to higher sales, while development-related costs for the next-generation POS system and the burden of upfront investments reduced earnings. |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales increased as our core contact lens business remained solid, while rising raw material costs and upfront investments reduced operating income. Net income was also affected by an extraordinary loss of ¥32.482 million.